Migraine stigma and general knowledge of migraine: A cross-sectional European survey

Otros/as autores/as

Institut Català de la Salut

[Goadsby PJ] NIHR-King’s Clinical Research Facility, NIHR-SLaM Biomedical Research Centre, Institute of Psychiatry, Psychology and Neuroscience, King’s College London, London, UK. [Ruiz de la Torre E] European Migraine and Headache Alliance, Brussels, Belgium. [Maassen van den Brink A] Department of Internal Medicine, Erasmus MC Medical Center, Rotterdam, The Netherlands. [Irimia P] Department of Neurology, Headache Unit, University Clinic of Navarra, Pamplona, Spain. [Mitsikostas DD] 1st Department of Neurology, Aeginition Hospital, National and Kapodistrian University of Athens, Athens, Greece. [Ashina M] Department of Neurology, Danish Headache Center, Copenhagen University Hospital – Rigshospitalet, Copenhagen, Denmark. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark. [Pozo-Rosich P] Unitat de Cefalees, Servei de Neurologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain

Vall d'Hebron Barcelona Hospital Campus

Fecha de publicación

2025-11-06T13:58:40Z

2025-11-06T13:58:40Z

2025-09



Resumen

Stigma scale for chronic illnesses 8-item; General population knowledge; Severe migraine


Escala de estigma para enfermedades crónicas de 8 ítems; Conocimiento de la población general; Migraña severa


Escala d'estigma per a malalties cròniques de 8 ítems; Coneixement de la població general; Migranya severa


Background The stigma associated with migraine impacts patients’ quality of life, mental health and their willingness to seek treatment. The present study aimed to gain insights into the stigma from the patient's perspective and to assess migraine knowledge among people without the condition. Methods This cross-sectional descriptive, quantitative study used two surveys (survey 1, open April 2023 to July 2023; survey 2, September 2023 to November 2023). The surveys were distributed to local patient organisations across 26 European countries and nine countries in South and North America, Asia and Oceania. Results Survey 1 received 3712 answers. Most respondents were women (3444; 92.8%), 45–54 years (1090; 29.4%) and experienced severe migraine (2047; 55.1%). Most participants viewed their migraine as disabling (2655; 71.5%) and felt that medical professionals only partially understood (2135; 57.5%). Survey 2 gathered 774 responses, with most of the participants being partners (202; 26.1%), friends (196; 25.3%) or other relatives (110; 14.2%) of individuals with migraine. The significant majority of respondents demonstrated a high understanding of migraine (573; 74.0%) and predominantly recognised migraine as disabling and impacting personal and professional life. Responders felt a high degree of stigma, more from work colleagues and medical professionals than from their social network. Conclusions The disabling nature of migraine, combined with the associated stigma, aggravates the challenges faced by patients. There is an urgent need for improved medical education, public awareness campaigns and possible revisions in medical terminology to better support people with migraine and mitigate the stigma they encounter. Importantly, medical professionals need to re-double efforts to check their behaviour to avoid adding to the burden of our patients.

Tipo de documento

Artículo


Versión publicada

Lengua

Inglés

Publicado por

SAGE Publications

Documentos relacionados

Cephalalgia;45(9)

https://doi.org/10.1177/03331024251368251

Citación recomendada

Esta citación se ha generado automáticamente.

Derechos

Attribution 4.0 International

http://creativecommons.org/licenses/by/4.0/

Este ítem aparece en la(s) siguiente(s) colección(ones)